SATURDAY, June 2, 2018 -- Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests.
Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for black men was initially the same as for white men -- an average of 21 months..
Thanks for being a subscriber.
Sorry, your subscription does not include this content.
Please call 866-589-5105 to upgrade your subscription.